Correlation between cerebral neurotransmitters levels by proton magnetic resonance spectroscopy and HbA1c in patients with type 2 diabetes

doi:10.4239/wjd.v15.i6.1263

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1250)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

HTML

722

Figures (1-1)

123

Tables (1-4)

121

Sum=1001

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

154

Sum=203

Jun 15, 2024 (publication date) through Nov 28, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. Jun 15, 2024; 15(6): 1263-1271
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1263

Open in New Tab Full Size Figure Download Figure

Figure 1 Cerebral neurotransmitters concentrations measured using proton magnetic resonance spectroscopy with different levels of hemoglobin A1c in patients with type 2 diabetes mellitus. A: N-acetylaspartate/creatine (NAA/Cr, left hippocampus); B: Choline (Cho)/Cr (left hippocampus); C: NAA/Cho (left hippocampus); D: NAA/Cr (left brainstem area); E: Cho/Cr (left brainstem area); F: NAA/Cho (left brainstem area). Q1: Hemoglobin A1c (HbA1c) < 7.875%; Q2: HbA1c 7.875%-9.050%; Q3: HbA1c 9.050%-11.200%; Q4: HbA1c ≥ 11.200%. NAA: N-acetylaspartate; Cr: Creatine; Cho: Choline.

Citation: Gao XY, Zhou CX, Li HM, Cheng M, Chen D, Li ZY, Feng B, Song J. Correlation between cerebral neurotransmitters levels by proton magnetic resonance spectroscopy and HbA1c in patients with type 2 diabetes. World J Diabetes 2024; 15(6): 1263-1271
URL: https://www.wjgnet.com/1948-9358/full/v15/i6/1263.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i6.1263